LBRX Competitors & Alternatives
Compare LB Pharmaceuticals Inc Common Stock with similar stocks in the same industry
Biotechnology
LBRX
Main Stock$39.42
Tradestie Score
46
Market Cap
$353.70M
P/E Ratio
392.3
Analyst Upside
+47.1%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$13.57
|
$1.35B | - | 61 | Compare |
|
RAPP
Rapport Therapeutics, Inc. Common Stock
|
$26.53
|
$1.32B | - | 54 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$10.86
|
$1.29B | - | 30 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$25.70
|
$1.29B | - | 51 | Compare |
|
ARDX
Ardelyx, Inc.
|
$3.20
|
$1.29B | - | 72 | Compare |
|
ZYME
Zymeworks Inc.
|
$28.44
|
$1.28B | - | 35 | Compare |
|
NUVB
Nuvation Bio Inc.
|
$4.70
|
$1.27B | - | 77 | Compare |
|
CVAC
CureVac N.V. Ordinary Shares
|
$4.66
|
$1.22B | 7.0 | 54 | Compare |
|
ATAI
ATAI Life Sciences N.V. Common Shares
|
$7.35
|
$1.22B | - | 44 | Compare |
|
PGEN
Precigen, Inc. Common Stock
|
$6.39
|
$1.18B | - | 61 | Compare |
More LBRX Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2834)
220 stocks in this industry